Insulet Corporation (PODD): insider & executive buying
Insulet Corporation · Health Care · ref. ETF XLV · price $143.41
In short — 3 insiders bought Insulet Corporation over ~6 months (3 buys, total $1.1M, latest Aug 21, 26) — cluster buy. Public Form 4 data, informative (not a performance signal).
Are Insulet Corporation's executives buying their own shares? Here are the disclosed insider buys over the last 6 months — a transparency data point, not an outperformance signal.
📈 1-year price
$143.41-57.5% over range
Aug 28, 25low $133.26 · high $352.82Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
50% recommend buying · 20 analysts
Latest insider buys on Insulet Corporation
| Date | Insider | Role | Shares | Amount |
|---|---|---|---|---|
| Aug 21, 26 | McEvoy Ashley | Pres, CEO | 1,100 | $162k |
| Jun 3, 26 | Stonesifer Timothy C. | Dir | 2,790 | $400k |
| Jun 3, 26 | Weatherman Elizabeth H | Dir | 3,450 | $497k |
⚠️ Open-market buys reported to the SEC (Form 4). Transparency data, not advice nor an outperformance signal (our backtests show no reliable edge).
Frequently asked questions
Have Insulet Corporation's executives bought shares recently?
3 Insulet Corporation insider(s) bought $1.1M over ~6 months (latest Aug 21, 26). A buy shows confidence, but our backtests show no performance edge.
Is insider buying a good signal for PODD?
It's useful transparency data, but NOT a performance guarantee: our historical tests show no reliable edge from following insider buys. Cross-check with fundamentals and analyst views.
Where does this data come from?
From Form 4 filings with the SEC (mandatory for officers and 10%+ holders), aggregated and refreshed regularly.
💬 A question about Insulet Corporation? The JPI assistant answers using our backtest data.